|
1
|
Lara AR and Schwarz MI: Diffuse alveolar
hemorrhage. Chest. 137:1164–1171. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nevel RJ, Deutsch GH, Craven D, Deterding
R, Fishman MP, Wambach JA, Casey A, Krone K, Liptzin DR, O'Connor
MG, et al: The US national registry for childhood interstitial and
diffuse lung disease: Report of study design and initial enrollment
cohort. Pediatr Pulmonol. 59:2236–2246. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bernardinello N, Griese M, Borie R and
Spagnolo P: Emerging treatments for childhood interstitial lung
disease. Paediatr Drugs. 26:19–30. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
van den Bosch L, Luppi F, Ferrara G and
Mura M: Immunomodulatory treatment of interstitial lung disease.
Ther Adv Respir Dis. 16:175346662211170022022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xie J, Zhao YY, Liu J and Nong GM: Diffuse
alveolar hemorrhage with histopathologic manifestations of
pulmonary capillaritis: Three case reports. World J Clin Cases.
8:2662–2666. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yazici H, Seyahi E, Hatemi G and Yazici Y:
Behçet syndrome: A contemporary view. Nat Rev Rheumatol.
14:107–119. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Al-Adhoubi NK and Bystrom J: Systemic
lupus erythematosus and diffuse alveolar hemorrhage, etiology and
novel treatment strategies. Lupus. 29:355–363. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guo S, Yin J, Yao Y, Chen L, Wang H, Zhao
Z, Xu B and Liu X: Juvenile idiopathic arthritis presenting as
diffuse alveolar hemorrhage at onset: A case series. Pediatr
Pulmonol. 58:3040–3045. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Saha BK, Aiman A, Chong WH, Saha S, Song J
and Bonnier A: Updates in idiopathic pulmonary hemosiderosis in
2022: A state of the art review. Pediatr Pulmonol. 58:382–391.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qi Y, Wang L, Qian L and Zhang X: The
etiology, clinical profile, and outcome of diffuse alveolar
hemorrhage in children: A ten-year single-center experience. Transl
Pediatr. 10:2921–2928. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Knoflach K, Rapp CK, Schwerk N, Carlens J,
Wetzke M, Emiralioğlu N, Kiper N, Ring AM, Buchvald F, Manali E, et
al: Diffuse alveolar hemorrhage in children with interstitial lung
disease: Determine etiologies! Pediatr Pulmonol. 58:1106–1121.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Le Clainche L, Le Bourgeois M, Fauroux B,
Forenza N, Dommergues JP, Desbois JC, Bellon G, Derelle J, Dutau G,
Marguet C, et al: Long-term outcome of idiopathic pulmonary
hemosiderosis in children. Medicine (Baltimore). 79:318–326. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang M, Liu ZQ, Wang Y, Luo LL and Qiao
LN: Successful treatment of diffuse alveolar hemorrhage secondary
to Mycoplasma pneumoniae complicated with hemophagocytic
lymphohistiocytosis in children: A case report and non-systematic
literature review. Front Pediatr. 12:14048722024. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cousin E, Gaillot T, Ozanne B, Ryckewaert
A, Dessard S, Tirel O and Fausser JL: A rare association between
group A Streptococcus purpura fulminans and diffuse alveolar
hemorrhage in a young girl: A case report. Arch Pediatr.
28:488–490. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Saha BK and Chong WH: Diffuse alveolar
hemorrhage in cardiac diseases. Lung. 199:103–112. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cohen SP, Eisner M, Fussner LA and
Krivchenia K: Diffuse alveolar hemorrhage in pediatrics: Etiologies
and outcomes. Pediatr Pulmonol. 59:3364–3370. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kang S, Cho MH, Hyun H, Kim JH, Ko JS,
Kang HG, Cheong HI, Kim WS, Moon KC and Ha IS: A pediatric Case of
a D-Penicillamine Induced ANCA-associated vasculitis manifesting a
pulmonary-renal syndrome. J Korean Med Sci. 34:e1732019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yao Y, Baoping X, Xiu-Yun L and Zhi-Peng
Z: Diffuse alveolar hemorrhage in a boy with combined methylmalonic
acidemia and homocysteinemia. Pediatr Pulmonol. 55:2208–2210. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Barker TT, Lee PY, Kelly-Scumpia KM,
Weinstein JS, Nacionales DC, Kumagai Y, Akira S, Croker BP, Sobel
ES, Reeves WH and Satoh M: Pathogenic role of B cells in the
development of diffuse alveolar hemorrhage induced by pristane. Lab
Invest. 91:1540–1550. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shiozawa S: Pathogenesis of
autoimmunity/systemic lupus erythematosus (SLE). Cells.
14:10802025. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shimojima Y, Kishida D, Ichikawa T and
Sekijima Y: Impact of NF-κB and reactive oxygen species on
intracellular BAFF/APRIL expression in ANCA-associated vasculitis:
Focusing on the effect of resveratrol. Front Immunol.
16:15861582025. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jennette JC and Falk RJ: Pathogenesis of
antineutrophil cytoplasmic autoantibody-mediated disease. Nat Rev
Rheumatol. 10:463–473. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kallenberg CG: Key advances in the
clinical approach to ANCA-associated vasculitis. Nat Rev Rheumatol.
10:484–493. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nakazawa D, Masuda S, Tomaru U and Ishizu
A: Pathogenesis and therapeutic interventions for ANCA-associated
vasculitis. Nat Rev Rheumatol. 15:91–101. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Holden NJ, Williams JM, Morgan MD, Challa
A, Gordon J, Pepper RJ, Salama AD, Harper L and Savage CO:
ANCA-stimulated neutrophils release BLyS and promote B cell
survival: A clinically relevant cellular process. Ann Rheum Dis.
70:2229–2233. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Merino-Vico A, van Hamburg JP and Tas SW:
B lineage cells in ANCA-Associated vasculitis. Int J Mol Sci.
23:3872021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Specks U, Merkel PA, Seo P, Spiera R,
Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ,
Ding L, et al: Efficacy of remission-induction regimens for
ANCA-associated vasculitis. N Engl J Med. 369:417–427. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
González-Treviño M, Figueroa-Parra G, Yang
JX, Prokop LJ, Gamal SM, García MA, James JA, Knight JS, Murad MH,
Narvaez J, et al: Association between antiphospholipid antibodies
and diffuse alveolar haemorrhage risk in systemic lupus
erythematosus: A systematic review and meta-analysis. Rheumatology
(Oxford). 64:1598–1608. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kazzaz NM, Coit P, Lewis EE, McCune WJ,
Sawalha AH and Knight JS: Systemic lupus erythematosus complicated
by diffuse alveolar haemorrhage: Risk factors, therapy and
survival. Lupus Sci Med. 2:e0001172015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Moura RA and Fonseca JE: B cells on the
stage of inflammation in juvenile idiopathic arthritis: Leading or
supporting actors in disease pathogenesis? Front Med (Lausanne).
9:8515322022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gkogkou E, Broux I, Kempeneers C, Boboli
H, Viellevoye R, Janssen A, Seghaye MC and Mastouri M: Diffuse
alveolar hemorrhage in infants: Report of five cases. Respir Med
Case Rep. 31:1011212020.PubMed/NCBI
|
|
32
|
Saha BK, Chong WH and Milman NT:
Differentiation of idiopathic pulmonary hemosiderosis from
rheumatologic and autoimmune diseases causing diffuse alveolar
hemorrhage: Establishing a diagnostic approach. Clin Rheumatol.
41:325–336. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kumasaka S, Kumasaka Y, Jingu A and
Tsushima Y: Diagnostic value of ‘hyperdense consolidation sign’ as
a characteristic new computed tomography sign of diffuse alveolar
hemorrhage. Sci Rep. 12:211432022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Traclet J, Lazor R, Cordier JF and Cottin
V: Alveolar hemorrhage. Rev Med Interne. 34:214–223. 2013.(In
French). View Article : Google Scholar : PubMed/NCBI
|
|
35
|
De Lassence A, Fleury-Feith J, Escudier E,
Beaune J, Bernaudin JF and Cordonnier C: Alveolar hemorrhage.
Diagnostic criteria and results in 194 immunocompromised hosts. Am
J Respir Crit Care Med. 151:157–163. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
World Health Organization (WHO), .
(2019/2021): International statistical classification of diseases
and related health problems, 11th revision (ICD-11). WHO; Geneva:
2022 June 5–2024https://icd.who.int/browse11/l-m/en
|
|
37
|
Maher TM: Interstitial lung disease: A
review. JAMA. 331:1655–1665. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Park JA: Treatment of diffuse alveolar
hemorrhage: Controlling inflammation and obtaining rapid and
effective hemostasis. Int J Mol Sci. 22:7932021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Clement A; ERS Task Force, : Task force on
chronic interstitial lung disease in immunocompetent children. Eur
Respir J. 24:686–697. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bush A, Cunningham S, de Blic J, Barbato
A, Clement A, Epaud R, Hengst M, Kiper N, Nicholson AG, Wetzke M,
et al: European protocols for the diagnosis and initial treatment
of interstitial lung disease in children. Thorax. 70:1078–1084.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ring AM, Schwerk N, Kiper N, Aslan AT,
Aurora P, Ayats R, Azevedo I, Bandeira T, Carlens J,
Castillo-Corullon S, et al: Diffuse alveolar haemorrhage in
children: An international multicentre study. ERJ Open Res.
9:00733–2022. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bradley B, Branley HM, Egan JJ, Greaves
MS, Hansell DM, Harrison NK, Hirani N, Hubbard R, Lake F, Millar
AB, et al: Interstitial lung disease guideline: The British
Thoracic Society in collaboration with the Thoracic Society of
Australia and New Zealand and the Irish Thoracic Society. Thorax.
63 (Suppl 5):v1–58. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Taytard J, Nathan N, de Blic J, Fayon M,
Epaud R, Deschildre A, Troussier F, Lubrano M, Chiron R, Reix P, et
al: New insights into pediatric idiopathic pulmonary hemosiderosis:
the French RespiRare(®) cohort. Orphanet J Rare Dis.
8:1612013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Raghu G, Montesi SB, Silver RM, Hossain T,
Macrea M, Herman D, Barnes H, Adegunsoye A, Azuma A, Chung L, et
al: Treatment of systemic sclerosis-associated interstitial lung
disease: evidence-based recommendations. An official American
thoracic society clinical practice guideline. Am J Respir Crit Care
Med. 209:137–152. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Manfredi A, Salvarani C and Sebastiani M:
Rituximab for connective tissue disease-associated interstitial
lung disease. Lancet Respir Med. 11:3–4. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xu L, Wang F and Luo F: Rituximab for the
treatment of connective tissue disease-associated interstitial lung
disease: A systematic review and meta-analysis. Front Pharmacol.
13:10199152022. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Weiner GJ: Rituximab: Mechanism of action.
Semin Hematol. 47:115–123. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Pescovitz MD: Rituximab, an anti-cd20
monoclonal antibody: History and mechanism of action. Am J
Transplant. 6((5 Pt 1)): 859–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Stone JH, Merkel PA, Spiera R, Seo P,
Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A,
Tchao NK, et al: Rituximab versus cyclophosphamide for
ANCA-associated vasculitis. N Engl J Med. 363:221–232. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Niles J: Rituximab in induction therapy
for anti-neutrophil cytoplasmic antibody (ANCA) vasculitis. Clin
Exp Immunol. 164 (Suppl 1):S27–S30. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Cartin-Ceba R, Diaz-Caballero L, Al-Qadi
MO, Tryfon S, Fervenza FC, Ytterberg SR and Specks U: Diffuse
alveolar hemorrhage secondary to antineutrophil cytoplasmic
antibody-associated vasculitis: Predictors of respiratory failure
and clinical outcomes. Arthritis Rheumatol. 68:1467–1476. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Freitas A, Senra V, Marinho A and Guedes
M: Chronic alveolar haemorrhage in a paediatric patient: A
diagnostic and treatment challenge. BMJ Case Rep.
2015:bcr20142068562015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Buonsenso D: A call to invest in
immunological determinants of pediatric post-COVID conditions:
Insights from a post-COVID pANCA+ diffuse alveolar hemorrhage in an
adolescent. Pediatr Pulmonol. 57:2861–2862. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Anderson A, Bartlett B, Chally J and
Malicki J: Antineutrophil cytoplasmic antibody-associated
vasculitis in a pediatric patient presenting with hemoptysis.
Cureus. 16:e686312024.PubMed/NCBI
|
|
55
|
Thompson G, Specks U and Cartin-Ceba R:
Isolated pauciimmune pulmonary capillaritis successfully treated
with rituximab. Chest. 147:e134–e136. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Rayment JH, Cutz E, Levy DM and Dell SD:
Concomitant diffuse alveolar hemorrhage and pulmonary embolism in a
child with isolated pulmonary capillaritis. Ann Am Thorac Soc.
14:470–473. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lewinter KE, Cidon M, Warren M and Bansal
M: Successful induction treatment with rituximab of isolated
pauci-immune pulmonary capillaritis presenting as diffuse alveolar
hemorrhage in a pediatric patient. Chest. 158:e225–e227. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Ivković V, Bajema I, Bruchfeld A, McAdoo
S, Kumar A, Klaus R, Kanzelmeyer N, Touzot M, Maalouf G, Jaryal A,
et al: Efficacy and safety of rituximab in antiglomerular basement
membrane disease. Kidney Int Rep. 10:743–752. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Pusongchai T, Jungthirapanich J and
Khositseth S: Pediatric systemic lupus erythematosus in Thammasat
University Hospital. J Med Assoc Thai. 93 (Suppl 7):S283–S293.
2010.PubMed/NCBI
|
|
60
|
Pottier V, Pierrot M, Subra JF, Mercat A,
Kouatchet A, Parrot A and Augusto JF: Successful rituximab therapy
in a lupus patient with diffuse alveolar haemorrhage. Lupus.
20:656–659. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wang C, Simpkin C, Vielkind M, Galambos C,
Lin C, Liptzin DR and Curran ML: Childhood-Onset sjögren syndrome
presenting as pulmonary hemorrhage. Pediatrics.
148:e20200421272021. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Terheggen-Lagro SWJ, Haarman EG, Rutjes
NW, van den Berg JM and Schonenberg-Meinema D: Rituximab in
idiopathic pulmonary hemosiderosis in children: A novel and less
toxic treatment option. Pharmaceuticals (Basel). 15:15492022.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Bloom JL, Frank B, Weinman JP, Galambos C,
O'Leary ST, Liptzin DR and Fuhlbrigge RC: Diffuse alveolar
hemorrhage in children with trisomy 21. Pediatr Rheumatol Online J.
19:1142021. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Telencoe S, Kevat AC, Lee AF and Rayment
JH: Diffuse alveolar haemorrhage in a child with trisomy 21. J
Paediatr Child Health. 57:1683–1685. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Hamrick L, Deskins SJ and Al-Qatarneh S:
Diffuse alveolar hemorrhage in a pediatric patient with systemic
lupus erythematosus. Pediatr Pulmonol. 58:1269–1271. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Fan K, Hurley C, McNeil MJ, Agulnik A,
Federico S, Qudeimat A, Saini A, McArthur J, Morrison RR, Sandhu H,
et al: Case report: Management approach and use of extracorporeal
membrane oxygenation for diffuse alveolar hemorrhage after
pediatric hematopoietic cell transplant. Front Pediatr.
8:5876012021. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Matsumoto S and Nakagawa S: Extracorporeal
membrane oxygenation for diffuse alveolar hemorrhage caused by
idiopathic pulmonary hemosiderosis: A case report and a review of
the literature. J Pediatr Intensive Care. 8:181–186. 2019.
View Article : Google Scholar : PubMed/NCBI
|
